>>Genentech Announces June 2 Webcast Discussion of Lucentis Data Presented at the 2006 Retinal Physician Symposium
Friday May 19, 5:02 pm ET
SOUTH SAN FRANCISCO, Calif., May 19 /PRNewswire-FirstCall/ -- Genentech, Inc. (NYSE: DNA ) invites investors, the media and the general public to listen to an audio webcast discussing the Lucentis Phase IIIb PIER data which is to be presented at the 2006 Retinal Physician Symposium in the Bahamas on June 2, 2006.
The live webcast will begin at 10:00 a.m. Pacific Time on June 2, 2006. The webcast can be accessed on Genentech's web site at gene.com and will be archived and available for replay until 5:00 p.m. Pacific Time on June 9, 2006. A telephonic replay will also be available beginning at 1:00 p.m. Pacific Time on June 2, 2006 through 5:00 p.m. Pacific Time on June 9, 2006. Access numbers for this replay are: 1-800-642-1687 (U.S./Canada) and 1-706-645-9291 (international); Conference ID number is 9427739.<<
snip
This will likely effect OSIP. My June 30 calls I used to hedge my little position expired worthless, so I will look for a bounce to rehedge. The investment community is watching this, and if there is a rise in OSI price near-term, I'd have to think it was anticipation of less than stellar data out of PIER. It is not something I'd want to gamble on, hence the hedging on such a rise.
Unless someone has a reasonable rationale for expecting less than stellar data out of PIER.
I'm all ears.
Cheers, Tuck |
